Evidence map›Paper›PMID 11150315›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

Nerve growth factor, but not epidermal growth factor, increases Fra-2 expression and alters Fra-2/JunD binding to AP-1 and CREB binding elements in pheochromocytoma (PC12) cells.

V Boss, J D Roback, A N Young, L J Roback, D M Weisenhorn, R Medina-Flores, B H Wainer

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Modulation of neurotrophic signaling pathways by polyphenols.Drug design, development and therapy · 2016
    Review
  5. Review
  6. Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

V BossDepartments of Pharmacology and Pathology, Emory University School of Medicine, Atlanta, Georgia 30329, USA.
J D Roback
A N Young
L J Roback
D M Weisenhorn
R Medina-Flores
B H Wainer
Emory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In pheochromocytoma (PC12) cells nerve growth factor (NGF) and epidermal growth factor (EGF) activate similar receptor tyrosine kinase signaling pathways but evoke strikingly different biological outcomes: NGF induces differentiation and EGF acts as a mitogen. A novel approach was developed for identifying transcription factor activities associated with NGF-activated, but not EGF-activated, signaling, using random oligonucleotide clones from a DNA recognition library to isolate specific DNA binding proteins from PC12 nuclear extracts. A protein complex from NGF-treated, but not EGF-treated, cells was identified that exhibits increased mobility and DNA binding activity in gel mobility shift assays. The binding complex was identified in supershift assays as Fra-2/JunD. The clones used as probes contain either AP-1 or cAMP response element binding (CREB) recognition elements. Time course experiments revealed further differences in NGF and EGF signaling in PC12 cells. NGF elicits a more delayed and sustained ERK phosphorylation than EGF, consistent with previous reports. Both growth factors transiently induce c-fos, but NGF evokes a greater response than EGF. NGF specifically increases Fra-1 and Fra-2 levels at 4 and 24 hr. The latter is represented in Western blots by bands in the 40-46 kDa range. NGF, but not EGF, enhances the upper bands, corresponding to phosphorylated Fra-2. These findings suggest that prolonged alterations in Fra-2 and subsequent increases in Fra-2/JunD binding to AP-1 and CREB response elements common among many gene promoters could serve to trigger broadly an NGF-specific program of gene expression.

Indexed as

AnimalsBinding SitesCell DifferentiationCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsEpidermal Growth FactorFos-Related Antigen-2Gene Expression Regulation, NeoplasticMitogen-Activated Protein KinasesMutagenesis, Site-DirectedNerve Growth FactorPC12 CellsPhosphorylationProto-Oncogene Proteins c-junRatsRegulatory Sequences, Nucleic AcidCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsEpidermal Growth FactorFosl2 protein, ratFos-Related Antigen-2Mitogen-Activated Protein KinasesNerve Growth FactorProto-Oncogene Proteins c-junTranscription Factor AP-1Transcription Factors

Identifiers

PMID11150315
PMCPMC6762456
OpenAlexW1911828269

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.